Literature DB >> 8540703

Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis.

J L Mainardi1, L Gutmann, J F Acar, F W Goldstein.   

Abstract

The antibacterial efficacy of the combination of amoxicillin and cefotaxime was assessed against 50 clinical strains of Enterococcus faecalis. For 48 of 50 strains, the MIC of amoxicillin that inhibited 50% of isolates tested decreased from 0.5 microgram/ml (range, 0.25 to 1 microgram/ml) to 0.06 microgram/ml (range, 0.01 to 0.25 microgram/ml) in the presence of only 4 micrograms of cefotaxime per ml. Alternatively, the MIC of cefotaxime that inhibited 50% of isolates tested decreased from 256 micrograms/ml (range, 8 to 512 micrograms/ml) to 1 micrograms/ml (range, 0.5 to 16 micrograms/ml) in the presence of only 0.06 microgram of amoxicillin per ml. For JH2-2, a reference strain of E. faecalis, the MICs of amoxicillin, cefotaxime, and amoxicillin in the presence of cefotaxime (4 micrograms/ml) were 0.5, 512, and 0.06 microgram/ml, respectively. By using a penicillin-binding protein (PBP) competition assay, it was shown that with cefotaxime, 50% saturation of PBPs 2 and 3 was obtained at very low concentrations (< 1 microgram/ml), while 50% saturation of PBPs 1, 4, and 5 was obtained with > or = 128 micrograms/ml. With amoxicillin, 50% saturation of PBPs 4 and 5 was obtained at 0.12 and 0.5 microgram/ml, respectively. Therefore, the partial saturation of PBPs 4 and 5 by amoxicillin combined with the total saturation of PBPs 2 and 3 by cefotaxime could be responsible for the observed synergy between these two compounds.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8540703      PMCID: PMC162868          DOI: 10.1128/AAC.39.9.1984

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Modification of penicillin-binding proteins of penicillin-resistant mutants of different species of enterococci.

Authors:  S al-Obeid; L Gutmann; R Williamson
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

2.  Use of penicillin-binding proteins for the identification of enterococci.

Authors:  R Williamson; L Gutmann; T Horaud; F Delbos; J F Acar
Journal:  J Gen Microbiol       Date:  1986-07

3.  Correlation of penicillin-induced lysis of Enterococcus faecium with saturation of essential penicillin-binding proteins and release of lipoteichoic acid.

Authors:  S al-Obeid; L Gutmann; R Williamson
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

4.  Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study.

Authors:  M J Zervos; C A Kauffman; P M Therasse; A G Bergman; T S Mikesell; D R Schaberg
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

5.  High-level vancomycin-resistant enterococci causing hospital infections.

Authors:  A H Uttley; R C George; J Naidoo; N Woodford; A P Johnson; C H Collins; D Morrison; A J Gilfillan; L E Fitch; J Heptonstall
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

6.  In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.

Authors:  R Fontana; A Grossato; M Ligozzi; E A Tonin
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 7.  Resistance to vancomycin and teicoplanin: an emerging clinical problem.

Authors:  A P Johnson; A H Uttley; N Woodford; R C George
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

8.  Streptococcus faecium mutants that are temperature sensitive for cell growth and show alterations in penicillin-binding proteins.

Authors:  P Canepari; M M Lleò; R Fontana; G Satta
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

9.  Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes.

Authors:  A E Jacob; S J Hobbs
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

10.  Studies on the mechanism of intrinsic resistance to beta-lactam antibiotics in group D streptococci.

Authors:  R Williamson; S B Calderwood; R C Moellering; A Tomasz
Journal:  J Gen Microbiol       Date:  1983-03
View more
  39 in total

1.  Enterococcal endocarditis: can we win the war?

Authors:  Jose M Munita; Cesar A Arias; Barbara E Murray
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 2.  Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.

Authors:  Sebastiano Leone; Silvana Noviello; Silvano Esposito
Journal:  Infection       Date:  2015-09-01       Impact factor: 3.553

3.  Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.

Authors:  Megan K Luther; Louis B Rice; Kerry L LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 4.  Novel Strategies for the Management of Vancomycin-Resistant Enterococcal Infections.

Authors:  German A Contreras; Jose M Munita; Cesar A Arias
Journal:  Curr Infect Dis Rep       Date:  2019-05-22       Impact factor: 3.725

5.  Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Simulated Endocardial Vegetations.

Authors:  Brian J Werth; Laura M Shireman
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

6.  β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.

Authors:  Jordan R Smith; Katie E Barber; Animesh Raut; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

7.  Enterococci and Their Interactions with the Intestinal Microbiome.

Authors:  Krista Dubin; Eric G Pamer
Journal:  Microbiol Spectr       Date:  2014-11

Review 8.  A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis.

Authors:  Maya Beganovic; Megan K Luther; Louis B Rice; Cesar A Arias; Michael J Rybak; Kerry L LaPlante
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

Review 9.  The Enterococcus: a Model of Adaptability to Its Environment.

Authors:  Mónica García-Solache; Louis B Rice
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

10.  β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

Authors:  Jordan R Smith; Katie E Barber; Animesh Raut; Mostafa Aboutaleb; George Sakoulas; Michael J Rybak
Journal:  J Antimicrob Chemother       Date:  2015-02-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.